GAIA BioMedicine None
GAIA BioMedicine is a biopharmaceutical company that was founded in 2015 as a spin-off venture of Kyushu University. The company specializes in developing cell treatments and immunotherapies for intractable malignancies. Its name reflects its vision to fight diseases with the strength of genes and the immune system.
Headquarters:
Fukuoka, Fukuoka, Japan
Estimated Revenue:
$20 million